Female sexual dysfunction: A case study of disease mongering and activist resistance

PLoS Medicine

Volumn 3, Issue 4, 2006, Pages 436-440

  Tiefer, Leonore ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RISEDRONIC ACID; SILDENAFIL; TESTOSTERONE;

DRUG INDUSTRY; FEMALE SEXUAL DYSFUNCTION; FOOD AND DRUG ADMINISTRATION; HUMAN; INTERNET; MATERNAL WELFARE; PAGET BONE DISEASE; REVIEW; SEXUAL AROUSAL; SEXUAL BEHAVIOR; SEXUAL EDUCATION; SEXUAL FUNCTION; SEXUALITY; ADVERTIZING; ARTICLE; CLASSIFICATION; CULTURAL FACTOR; FEMALE; HISTORY; NOMENCLATURE; PATIENT ADVOCACY; PUBLISHING; SEXUAL DYSFUNCTION; SOCIAL STATUS;

ADVERTISING AS TOPIC; CULTURAL CHARACTERISTICS; DRUG INDUSTRY; FEMALE; HISTORY, 20TH CENTURY; HUMANS; JOURNALISM, MEDICAL; PATIENT ADVOCACY; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SEXUALITY; SOCIAL CONDITIONS; TERMINOLOGY AS TOPIC;

EID: 33646261634     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0030178     Document Type: Review

References (49)

1. Payer L (1992) Disease-mongers: How doctors, drug companies, and insurers are making you feel sick. New York: Wiley & Sons. 292 p.
2. Critser G (2005) Generation Rx: How prescription drugs are altering American lives, minds, and bodies. Boston: Houghton-Mifflin. 308 p.
3. Peiss KL (1986) Cheap amusements: Working women and leisure in turn-of-the century New York. Philadelphia: Temple University Press. 244 p.
4. D'Emilio J, Freedman EB (1988) Intimate matters: A history of sexuality in America. New York: Harper & Row. 428 p.
5. Ericksen JA, Steffen SA (1999) Kiss and tell: Surveying sex in the twentieth century. Cambridge (Massachusetts): Harvard University Press. 270 p.
6. Weeks J (1985) Sexuality and its discontents: Meanings, myths and modern sexualities. London: Routledge & Kegan Paul. 324 p.
7. Tiefer L (2004) Sex is not a natural act and other essays, 2nd edition. Boulder (Colorado): Westview Press. 304 p.
8. The National Institutes of Health Consensus Development Program (1992) Impotence. NIH Consensus Statement Online 1992 Dec 7-9 10: 1-31. Available: http://consensus.nih.gov/1992/1992Impotence091html.htm. Accessed 7 March 2006.
9. Lexchin J (2006) Bigger and better: How Pfizer redefined erectile dysfunction. PLoS Med 3: e132. DOI: 10.1371/journal.pmed.0030132
10. Rosen RC, O'Leary MP (1997) Proceedings of The Cape Cod Conference: Sexual Function Assessment in Clinical Trials. Hyannis, Massachusetts, USA. 30-31 May 1997. Int J Impot Res 10 (Suppl 2): S1-S140.
11. Berman J, Berman L, Bumiller E (2001) For women only: A revolutionary guide to overcoming sexual dysfunction and reclaiming your sex life. New York: Henry Holt & Co. 269 p.
12. Goldstein I (2005) Inaugural supplement of The Journal of Sexual Medicine on women's sexual health concerns: Postmenopausal female sexual dysfunction roundtable. J Sex Med 2: 115. DOI: 10.1111/j.1743-6109.2005.00126.x
13. O'Connor AM (2005 October 2) Dr. Berman's Sex Rx. Los Angeles Times. Available: http://www.latimes.com/features/health/medicine/la-tm-sexresearch40oct02,1, 7694520. story. Accessed 13 March 2006.
14. Mayor S (2004) Pfizer will not apply for a license for sildenafil for women. BMJ 328: 542.
15. Murdock M (2000) Did it work? Viagra calls off clinical trials on use in women. Available: http://hisandherhealth.com/articles/noviagrawomen.shtml. Accessed 13 March 2006.
16. Procter & Gamble (2006) Prescription drugs. Available: http://www.pg.com/product_card/prod_card_rx_drugs.jhtml. Accessed 7 March 2006.
17. Procter & Gamble (2004) Earning your trust. Annual report. Available: http://www.pg.com/annualreports/2004/pdf/pg2004annualreport. pdf. Accessed 7 March 2006.
18. Zwillich T (2004) FDA rejects libido drug for women. Available: http://www.webmd.com/content/article/97/104342.htm. Accessed 7 March 2006.
19. Kantrowitz B, Wingert P (2005 October 4) Inside the struggle to treat women with dwindling sex drives. Newsweek. Available: http://msnbc.msn.com/id/9546806/site/newsweek. Accessed 7 March 2006.
20. Tiefer L (1999) "Female sexual dysfunction" alert: A new disorder invented for women. Sojourner: The Women's Forum. October: 11.
21. Tiefer L, Tavris C (1999 October 20). Viagra for women is the wrong Rx. Los Angeles Times: B9.
22. New View (2000)A new view of women's sexual problems. Available: http://www.fsd-alert.org/manifesto.html. Accessed 7 March 2006.
23. (2005) Women and the new sexual politics: Profits versus pleasures. Available: http://www.fsd-alert.org/Final%20Montreal%20conf%20report.pdf. Accessed 7 March 2006.
24. Freudenberg N (2005) Public health advocacy to change corporate practices: Implications for health education practice and research. Health Educ Behav 32: 298-319.
25. FDA Center for Biologics Evaluation and Research (2006) FDA Modernization Act of 1997. Available: http://www.fda.gov/cber/fdama.htm. Accessed 7 March 2006.
26. Bankhead C (1997) New field could open for urologists: Female sexual dysfunction. Urology Times 25: 1.
27. Park K, Goldstein I, Andry C, Siroky MB, Krane RJ, et al. (1997) Vasculogenic female sexual dysfunction: The hemodynamic basis for vaginal engorgement insufficiency and clitoral erectile insufficiency. Int J Impot Res 9: 27-38.
28. Johannes L (1998 July 13) Now, drug companies turn to women's sexual problems. Wall Street Journal: B1-B2.
29. Basson R, Berman J, Burnett A, Derogatis L, Ferguson D, et al. (2000) Report of the international consensus development conference on female sexual dysfunction: Definitions and classifications. J Urol 163: 888-893.
30. Laumann, EO, Paik A, Rosen RC (1999) Sexual dysfunction in the United States: Prevalence and predictors. JAMA 281: 537-544.
31. Billups KL, Berman L, Berman J, Metz ME, Glennon ME, et al. (2001) A new non-pharmacological vacuum therapy for female sexual dysfunction. J Sex Marital Ther 27: 435-441.
32. Center for Drug Evaluation and Research (2001) Female sexual dysfunction: Clinical development of drug products for treatment. Available: http://www.fda.gov/cder/guidance/3312dft.htm. Accessed 7 March 2006.
33. Procter & Gamble (2000) Testosterone skin patch improves sexual functioning in surgically menopausal women. Available: http://www.pginvestor.com/phoenix.zhtml?c=104574&p=irol-newsArticleMain& ID=628910. Accessed 7 March 2006.
34. Deer B (2003 September 28) Love sickness. The Sunday Times Magazine (London). Available: http://briandeer.com/sexual-disorder. htm. Accessed 7 March 2006.
35. The Age (2004) The passion patch. Available: http://www.theage.com.au/articles/2004/11/18/1100748140309.html. Accessed 7 March 2006.
36. Baylor College of Medicine (2006) About online meetings on female sexual dysfunction online. Available: http://www.femalesexualdysfunctiononline.org/meetings. Accessed 7 March 2006.
37. The North American Menopause Society (2005) The role of testosterone therapy in postmenopausal women: Position statement of The North American Menopause Society. Available: http://www.menopause.org/aboutmeno/PStestosterone.pdf. Accessed 20 March 2006.
38. Kong D (1999 October 22) Doubts heard over sexual dysfunction gathering. Boston Globe: B1, B6.
39. New View (2002) A new view of women's sexual problems. Available: http://www.fsd-alert.org/newbook.html. Accessed 7 March 2006.
40. New View (2002) Conference. The New "Female Sexual Dysfunction": Promises, Prescriptions, and Profits. March 9, 2002. Available: http://www.fsd-alert.org/2002conference.html. Accessed 7 March 2006.
41. Moynihan R (2003) The making of a disease: Female sexual dysfunction. BMJ 326: 45-47.
42. New View (2003) A new view of women's sexual problems: A teaching manual. Available: http://www.fsd-alert.org/ntm.html. Accessed 7 March 2006.
43. Kelleher S (2005) Clash over "little blue pill" for women. The Seattle Times. Available: http://seattletimes.nwsource.com/html/health/sick5.html. Accessed 7 March 2006.
44. Hicks KM (2005) The "new view" approach to women's sexual problems. Available: http://www.medscape.com/viewprogram/4705. Accessed 7 March 2006.
45. New View (2004) FDA hearing on Intrinsa. Dec. 2, 2004. New View resources. Available: http://www.fsd-alert.org/intrinsa.html. Accessed 7 March 2006.
46. Moynihan R (2005) The marketing of a disease: Female sexual dysfunction. BMJ 330: 192-194.
47. New View (2005) New View Conference 2005. Women and the New Sexual Politics: Profits vs. Pleasures. July 9-10, 2005. Available: http://www.fsd-alert.org/connewviewconf2005.html. Accessed 7 March 2006.
48. New View (2005) The New View campaign began a New View listserv in August, 2005. Available: http://www.fsd-alert.org/listserve.html. Accessed 7 March 2006.
49. Tiefer L (2005) Omissions, biases, and nondisclosed conflicts of interest: Is there a hidden agenda in the NAMS position statement? Available: http://www.medscape.com/viewarticle/513099. Accessed 13 March 2006.